Christine Lebrun-Frenay

Nice, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 234 publications

Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

Journal: Nature medicine

Published: July 09, 2026

Corrigendum to "A Pre-symptomatic phase of tumefactive multiple sclerosis mirrors radiologically isolated syndrome" [Multiple Sclerosis and Related Disorders 112 (2026) 107312].

Corrigendum to "A Pre-symptomatic phase of tumefactive multiple sclerosis mirrors radiologically isolated syndrome" [Multiple Sclerosis and Related Disorders 112 (2026) 107312].

Journal: Multiple sclerosis and related disorders

Published: July 07, 2026

Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.

Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.

Journal: Annals of clinical and translational neurology

Published: June 12, 2026

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 02, 2026

Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

Journal: Neurology

Published: May 29, 2026

Kappa free light chain index or oligoclonal bands testing in clinical practice for multiple sclerosis diagnosis: An algorithm comparative study.

Kappa free light chain index or oligoclonal bands testing in clinical practice for multiple sclerosis diagnosis: An algorithm comparative study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 06, 2026

Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

Journal: Neurology

Published: May 05, 2026

Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: April 28, 2026

Impact of cancer on multiple sclerosis-related healthcare and disease-modifying drug use: A multinational cohort study.

Impact of cancer on multiple sclerosis-related healthcare and disease-modifying drug use: A multinational cohort study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: April 05, 2026

Diagnosis of Multiple Sclerosis.

Diagnosis of Multiple Sclerosis.

Journal: Continuum (Minneapolis, Minn.)

Published: April 02, 2026

A Pre-symptomatic phase of tumefactive multiple sclerosis mirrors radiologically isolated syndrome.

A Pre-symptomatic phase of tumefactive multiple sclerosis mirrors radiologically isolated syndrome.

Journal: Multiple sclerosis and related disorders

Published: March 11, 2026

External validation and improvement of an algorithm that identifies multiple sclerosis relapses in the French national healthcare claims database.

External validation and improvement of an algorithm that identifies multiple sclerosis relapses in the French national healthcare claims database.

Journal: Multiple sclerosis and related disorders

Published: March 05, 2026

Showing 1-12 of 234

Last Updated: 09/26/2026